These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3056241)

  • 1. Structure-activity relationships of selected phenazines against Mycobacterium leprae in vitro.
    Franzblau SG; O'Sullivan JF
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1583-5. PubMed ID: 3056241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of tetramethylpiperidine-substituted phenazines against Mycobacterium leprae in vitro.
    Franzblau SG; White KE; O'Sullivan JF
    Antimicrob Agents Chemother; 1989 Nov; 33(11):2004-5. PubMed ID: 2692516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of phenazine analogs against Mycobacterium leprae infections in mice.
    Van Landingham RM; Walker LL; O'Sullivan JF; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):406-14. PubMed ID: 8228439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro investigation of the antimicrobial activities of novel tetramethylpiperidine-substituted phenazines against Mycobacterium tuberculosis.
    van Rensburg CE; Jooné GK; Sirgel FA; Matlola NM; O'Sullivan JF
    Chemotherapy; 2000; 46(1):43-8. PubMed ID: 10601797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activities of seven novel tetramethylpiperidine-substituted phenazines against multiple-drug-resistant Gram-positive bacteria.
    Huygens F; O'Sullivan JF; van Rensburg CE
    Chemotherapy; 2005 Aug; 51(5):263-7. PubMed ID: 16103666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofazimine analogues active against a clofazimine-resistant organism.
    O'Sullivan JF; Conalty ML; Morrison NE
    J Med Chem; 1988 Mar; 31(3):567-72. PubMed ID: 3279207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of experimental chemotherapy of leprosy.
    Banerjee DK
    Lepr India; 1976 Oct; 48(4 Suppl):686-9. PubMed ID: 800233
    [No Abstract]   [Full Text] [Related]  

  • 8. Minimal effective dosages in mice of clofazimine (B,663) and of ethionamide against Mycobacterium leprae.
    Shepard CC
    Proc Soc Exp Biol Med; 1969 Oct; 132(1):120-4. PubMed ID: 4899207
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro and in vivo interactions of drugs used in multidrug therapy in leprosy.
    Dhople AM; Lamoureux LC; Gardner GD
    Indian J Lepr; 1991; 63(2):166-79. PubMed ID: 1664440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Search for newer antileprosy drugs.
    Dhople AM
    Indian J Lepr; 2000; 72(1):5-20. PubMed ID: 10935183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo studies of the action of rifampicin, clofazimine and B1912 on Mycobacterium marinum.
    Banerjee DK; Holmes IB
    Chemotherapy; 1976; 22(3-4):242-52. PubMed ID: 1269290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clofazimine and other rimino-compounds: minimal inhibitory and minimal bactericidal concentrations at different pHs for Mycobacterium avium complex.
    Lindholm-Levy PJ; Heifets LB
    Tubercle; 1988 Sep; 69(3):179-86. PubMed ID: 3254636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug resistance of Mycobacterium leprae].
    Pattyn SR
    Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimycobacterial activities of riminophenazines.
    Reddy VM; O'Sullivan JF; Gangadharam PR
    J Antimicrob Chemother; 1999 May; 43(5):615-23. PubMed ID: 10382882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basic evaluation for new antimicrobial susceptibility testing of Mycobacterium leprae by bioluminescence assay (ATP method)].
    Yamazaki T; Gidoh M; Matsuoka M
    Nihon Hansenbyo Gakkai Zasshi; 2006 Sep; 75(3):227-37. PubMed ID: 17037377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid, radiometric in vitro assay for the evaluation of the anti-leprosy activity of clofazimine and its analogues.
    Mittal A; Seshadri PS; Conalty ML; O'Sullivan JF; Nath I
    Lepr Rev; 1985 Jun; 56(2):99-108. PubMed ID: 3894849
    [No Abstract]   [Full Text] [Related]  

  • 17. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
    Levy L; Shepard CC; Fasal P
    Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug susceptibility testing of Mycobacterium leprae in the BACTEC 460 system.
    Franzblau SG
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2115-7. PubMed ID: 2694952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance in leprosy: lessons from past and future perspective.
    Gupta UD; Katoch VM
    Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.